MEDSEARCH TECHNOLOGIES INC
10QSB/A, EX-27, 2000-07-24
MEDICAL LABORATORIES
Previous: MEDSEARCH TECHNOLOGIES INC, 10QSB/A, 2000-07-24
Next: MEDSEARCH TECHNOLOGIES INC, 10KSB/A, 2000-07-24



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEET AS OF MARCH 31, 2000 AND THE RELATED CONDENSED
STATEMENTS OF OPERATIONS FOR THE THREE MONTH PERIOD ENDED MARCH 31, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                     0001093759
<NAME>                    Medsearch Technologies, Inc.
<MULTIPLIER>                                         1
<CURRENCY>                                         USD

<S>                             <C>
<PERIOD-TYPE>                              3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                         148,877
<SECURITIES>                                         0
<RECEIVABLES>                                  572,618
<ALLOWANCES>                                   362,057
<INVENTORY>                                      6,900
<CURRENT-ASSETS>                               409,383
<PP&E>                                         146,064
<DEPRECIATION>                                  35,231
<TOTAL-ASSETS>                               1,844,378
<CURRENT-LIABILITIES>                          181,775
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         6,534
<OTHER-SE>                                   1,306,069
<TOTAL-LIABILITY-AND-EQUITY>                 1,844,378
<SALES>                                        163,278
<TOTAL-REVENUES>                               163,278
<CGS>                                           45,390
<TOTAL-COSTS>                                  345,686
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 810
<INCOME-PRETAX>                               (228,208)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (228,208)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (228,208)
<EPS-BASIC>                                       (.04)
<EPS-DILUTED>                                     (.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission